Avexa Limited is a Melbourne-based biotechnology company with a focus on research and development of drugs for the treatment of infectious diseases. The companys lead program is apricitabine (ATC), an anti-HIV drug.
| Registrars: |
| Address: | |
| Phone: | |
| Fax: | |
| Website: | |
| Email: |
| ISIN: | AU000000NHL8 |
| Main Indices: | ASX All Ordinaries |